9th Annual Biomarkers Congress

Epidemiology: The Mayo Clinic

Total Score People Score Events Score
68 62 19
Date Event Presentation Speakers
July 21, 2013 54th Annual Short Course on Medical and Experimental Mammalian Genetics Thur sday, July 25 Pharmacogenomics: Development, Science and Translation Richard M. Weinshilboum
May 31, 2013 ASCO Annual Meeting 2013 What's New and Improved in the Care of Children with Rhabdomyosarcoma? Carola A. S. Arndt
Responding to Common Concerns of Patients with Cancer: What's New—In a Nutshell—From Research to Therapeutic Strategies Charles L. Loprinzi
Uncommon Lymphoproliferative Disorders (C01) Angela Dispenzieri
Rationally Combining Targeted and Pathway-Specific Agents Edith A Perez
Special Session David P Steensma
Education Sessions Gloria M. Petersen
April 6, 2013 AACR Annual Meetings Targeting Lymphoid Malignancies: Working from the Outside In Co-Chairpersons: John P. Leonard, Weill Cornell Medical Center, New York, NY, and John C. Byrd, The Ohio State University Comprehensive Cancer Center, Columbus, OH James R. Cerhan
Endocrine Resistance in Breast Cancer Chairperson: Nancy E. Davidson, University of Pittsburgh Cancer Institute, Pittsburgh, PA Matthew P . Goetz
DNA Damage Response: What Do We Know Now and What Will We Learn Next? Chairperson: Junjie Chen, The University of Texas MD Anderson Cancer Center, Houston, TX Junjie Chen
Genetic Epidemiology of Pancreatic Cancer Gloria M. Petersen, Mayo Clinic College of Medicine, Rochester, MN Gloria M. Petersen
August 25, 2011 ACCP Sleep Medicine Board Review 2011 Sleep, Genetics, and Immunology James M. Parish
Sleep and Respiratory Disease | Pulmonary Arterial Hypertension, Asthma, Cystic Fibrosis, COPD, and Obesity Hypoventilation Syndrome James M. Parish
Sleep, Sleep Disorders, and Cognition Peter C. Gay
Snoring, Complex Sleep Apnea, Upper Airways Resistance Syndrome, and Non-CPAP Treatment for Obstructive Sleep Apnea Peter C. Gay
August 7, 2011 Success With Failure: New Strategies for the Evaluation and Treatment of Congestive Heart Failure Medical Management of Patients with Reduced Ejection Fraction Heart Failure, Outpatient vs. Inpatient | What’s the Same, What’s the Difference? Barry L. Karon
Heart Failure with Reduced Ventricular Function | Hemodynamics, Imaging, and Pathology Barry A. Borlaug, Barry L. Karon, Brooks S. Edwards
Epidemiology of Heart Failure Richard J. Rodeheffer
Integrating New Tools for the Diagnosis of Heart Failure | Metabolic Stress Testing, Neurohumoral Markers Grace Lin
Course Welcome Brooks S. Edwards
Early Bird Cases (Optional) Does the Patient Have Heart Failure? Farris K. Timimi
Heart Failure with Preserved Ejection Fraction | What Is It? Barry A. Borlaug
Managing the Heart Failure Reimbursement | Successful Strategic Partnering Michael A. Morrey
Surgical Adventures in Heart Failure Richard C. Daly, Joseph A. Dearani
Illustrative Cases: Tailored Outpatient Pharmacotherapy for the Patient with Systolic Dysfunction Farris K. Timimi, Barry A. Borlaug, Barry L. Karon, Richard J. Rodeheffer
Cardiac Resynchronization Therapy | When Medications Aren’t Enough Grace Lin
Illustrative Cases | Management of Inpatients with Acute Decompensated Heart Failure Barry A. Borlaug, Brooks S. Edwards
Palliative Care and its Role in Heart Failure Keith M. Swetz
Cardiorenal Syndrome in the Patient with Diuretic Resistance Margaret M. Redfield
Evaluating the Patient with Newly Diagnosed Diastolic Heart Failure Margaret M. Redfield
Heart Failure with Reduced Ventricular Function: Hemodynamics, Imaging, and Pathology for Patient with Preserved Ejection Fraction Barry A. Borlaug, Barry L. Karon, Brooks S. Edwards
Echo Cases in Heart Failure Margaret M. Redfield
Surgical Adventures in Heart Failure Richard C. Daly, Joseph A. Dearani
Stage D Heart Failure | End of Life Considerations Keith M. Swetz
Arrhythmia Cases in Heart Failure Paul A. Friedman
Patient Centered Approach to Managing Heart Failure | Lessons from the Patient Family Council Farris K. Timimi
Update in Heart Failure Trials | What’s Coming? Margaret M. Redfield
Medical and Surgical Cases in Advanced Heart Failure Joseph A. Dearani, Brooks S. Edwards
Cardiac Transplantation | It’s Evolving Role in the Era of Mechanical Circulatory Support Brooks S. Edwards
Surgical Perspectives: Approaches to Revascularization for Patients with Coronary Artery Disease and Congestive Heart Failure Joseph A. Dearani
Sudden Death in Heart Failure Patients Paul A. Friedman
Hypertrophic Cardiomyopathy | Medical and Surgical Perspectives Joseph A. Dearani, Barry L. Karon
Sleep Related Breathing Disorders in Heart Failure Farris K. Timimi
Challenging LVAD Cases Richard C. Daly, Brooks S. Edwards
Surgical Perspectives for Adult Patients with Congenital Heart Disease and Heart Failure Joseph A. Dearani
Perioperative Management of the Patient with Heart Failure Undergoing Non Cardiac Surgery Farris K. Timimi
Anemia, Uric Acid, and Nutraceuticals | What Does a Heart Failure Specialist Need to Know? Grace Lin
Device Programming in Heart Failure: What the Non Electrophysiologist Needs to Know Paul A. Friedman
Hemodynamic Cath Lab Assessments for Patients with Congestive Heart Failure Barry A. Borlaug
Early Bird Cases (Optional) Echo Characteristics of Heart Failure with Preserved EF: Is ECHO Friend or Foe? Barry L. Karon
July 28, 2011 International Conference on Biomedical Ontology A Case Study of ICD-11 Anatomy Value Set Extraction from SNOMED CT Harold Solbrig
Ontology and the Electronic Health Record Christopher G. Chute
Panel | Problems with Existing EHR Paradigms and How Ontology Can Solve Them Christopher G. Chute
March 1, 2011 "The Latest Advances in Liver Cancer Research: From Basic Science to Therapeutics" Session 2 | Epidemiology of HBV-related HCC W Ray Kim
November 7, 2010 Ninth Annual International Conference on Frontiers in Cancer Prevention Research Molecular genetic research: Translating discovery into risk assessment and genetic testing Gloria M. Petersen
Introduction Gloria M. Petersen
Educational Sessions-2 : Trends in Epidemiology Research Gloria M. Petersen
Phase 0 trial of SR13668, an orally active AKT inhibitor Joel M. Reid
Stool DNA testing to screen colorectal and other aerodigestive cancers David A. Ahlquist
Concurrent Sessions - 13 : Colon Cancer Prevention Paul J. Limburg
September 30, 2010 Third AACR Conference on The Science of Cancer Health Disparities A Native American community perspective Judith S. Kaur,
Personalizing cancer therapy: Implications for health disparities Alex A Adjei
Plenary Session 8: Personalizing Cancer Prevention and Therapy Alex A Adjei
August 24, 2010 Enabling Point-of-Care Diagnostics - Moving Towards Rapid Diagnosis Clinical Diagnostics – Where Are We Going? Franklin R. Cockerill III
June 6, 2010 The Future of Molecular Epidemiology: New Tools, Biomarkers, and Opportunities Educational Session 3: Use of Biomarkers in Epidemiology: Study Design and Sources of Biases James R. Cerhan
Welcome and Keynote Session: Where is Molecular Epidemiology? Thomas A Sellers
Overview Gloria M. Petersen
Session 4: Biomarkers of Intervention and Clinical Response Gloria M. Petersen
Title to be announced Gloria M. Petersen
Panel Discussion The Future - Towards The Integration of Biomarkers into Epidemiology Gloria M. Petersen
Session 6: Challenges II – How Can Biomarker Studies Contribute to Cancer Prevention? Thomas A Sellers
June 4, 2010 From Chronic Inflammation to Cancer Chronic pancreatitis and pancreatic cancer Santhi Swaroop Vege
January 22, 2010 2010 Gastrointestinal Cancers Symposium Oral Abstract Session: Cancers of the Esophagus and Stomach Michael G Haddock
FISH Analysis to Diagnose Biliary Cancers Gregory J. Gores
Minimally Invasive Surgical Approaches to Colorectal Cancer Heidi Nelson
New Screening Models: Blood, Stool, Capsule Endoscopy David A. Ahlquist
December 11, 2009 Santa Fe Gastrointestinal Cancer Conference Hepatocarcinogenesis of HCC Lewis R. Roberts
The Role of Liver Transplantation in Treating HCC Lewis R. Roberts
October 1, 2009 6TH ANNUAL MEETING OF THE INTERNATIONAL SOCIETY OF GASTROINTESTINAL ONCOLOGY (ISGIO) Panel Discussion With Interactive Q/A Axel Grothey
Case Presentation 2: Metastatic But Potentially Curable Axel Grothey
Case Presentation 3: Stage Iva After Primary Surgery for Synchronous Liver Metastases- Previously Untreated Axel Grothey
September 11, 2009 Mayo Clinic Stroke and Cerebrovascular Disease Review Telemedicine Bart M. Demaerschalk
Clinical Research and Outcomes Bart M. Demaerschalk
Pharmacology of Commonly Used Medications Karen M. Nau
Neuropathology of Stroke Dennis Dickson
Stroke Pathophysiology Edward M. Manno
Vascular Neuroanatomy Joseph M. Hoxworth
Management of Stroke Complications W. David Freeman
Genetic & Metabolic Disorders James F. Meschia
Pro-Thrombotic Causes of Stroke Candido E. Rivera
Non-Athero Non-Inflammatory Vasculopathies James F. Meschia
Lunch & Learn: Coding, Billing and Reimbursement Timothy Ingall
Cardiac Disorders and Management George W. Petty
Sleep and Stroke Pablo R. Castillo
Asymptomatic Carotid Occlusive Disease Kevin M. Barrett
Secondary Prevention Kelly D. Flemming
Epidemiology of Stroke and Risk Factors Kevin M. Barrett
Recovery, Regenerative Approaches and Rehabilitation Allen W. Brown
Spinal Cord Vascular Disease David A. Miller
Subarachnoid Hemorrhage Ricardo A. Hanel
Intracerebral Hemorrhage/Intraventricular Hemorrhage Maria I. Aguilar
Vascular Malformations Giuseppe Lanzino
Commonly Asked Questions in the Management of Unruptured Intracranial Aneurysms Robert D. Brown
August 11, 2009 Inaugural Clinical Adoption of Next Generation Diagnostics Tamoxifen and CYP2D6: Using Pharmacogenetics to Individualize Breast Cancer Hormonal Therapy Matthew P . Goetz
August 11, 2009 Inaugural Molecular Diagnostics for Infectious Disease Point-of-Care Diagnostics Franklin R. Cockerill
November 6, 2008 Adding, Updating and Expanding STROKE PROGRAMS AND SERVICE LINES TELESTROKE: EXTENDING THE REACH OF ACUTE STROKE TEAMS Bart M. , Demaerschalk
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.